Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Prospective, Open, Non-interventional Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen in the Clinical Routine of the IVF- / ICSI-treatment.

NCT02809989 is registered in ClinicalTrials.gov with Teva Pharma GmbH as lead sponsor.

NCT NCT02809989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02809989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Prospective, Open, Non-interventional Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen in the Clinical Routine of the IVF- / ICSI-treatment.
Lead sponsor
Teva Pharma GmbH
Phase
Observational
Overall status
Completed
Start date
March 31, 2016
Completion date
March 13, 2018
Enrollment
507 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

oocytes, pregnancy rate